Design and interpretation of studies of the risk of cancer and other long-term morbidity and mortality after growth hormone treatment.
Swerdlow
A J
AJ
Institute of Cancer Research, Sutton, UK. a.swerdlow@icr.ac.uk
D015331:Cohort Studies; D005500:Follow-Up Studies; D019382:Human Growth Hormone / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000453:epidemiology / Q000209:etiology* / Q000401:mortality*; D012107:Research Design; D012307:Risk Factors
D019382:Human Growth Hormone